US BANCORP \DE\ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,038
-12.3%
2,480
+100.3%
0.00%
Q2 2023$58,211
+8.6%
1,238
-3.1%
0.00%
Q1 2023$53,625
+21.9%
1,278
+10.8%
0.00%
Q4 2022$43,975
-21.5%
1,153
-19.6%
0.00%
Q3 2022$56,000
-6.7%
1,434
-23.0%
0.00%
Q2 2022$60,000
+27.7%
1,863
+32.5%
0.00%
Q1 2022$47,000
-33.8%
1,406
-15.3%
0.00%
Q4 2021$71,000
-15.5%
1,659
-12.0%
0.00%
Q3 2021$84,000
-5.6%
1,885
+19.7%
0.00%
Q2 2021$89,000
-26.4%
1,575
-1.9%
0.00%
Q1 2021$121,000
-54.7%
1,605
-48.1%
0.00%
-100.0%
Q4 2020$267,000
+54.3%
3,095
+9.1%
0.00%
Q3 2020$173,000
+355.3%
2,836
+213.0%
0.00%
Q2 2020$38,000
+137.5%
906
+62.7%
0.00%
Q1 2020$16,000
-15.8%
557
+114.2%
0.00%
Q4 2019$19,000
-88.8%
260
-78.5%
0.00%
Q3 2019$170,000
-17.1%
1,210
+7.8%
0.00%
-100.0%
Q2 2019$205,000
+22.0%
1,122
+6.2%
0.00%
Q1 2019$168,000
+5500.0%
1,056
+2475.6%
0.00%
Q4 2018$3,000
-97.5%
41
-95.2%
0.00%
Q3 2018$119,000
-10.5%
846
-0.9%
0.00%
Q2 2018$133,000
+6550.0%
854
+5593.3%
0.00%
Q1 2018$2,0000.0%150.0%0.00%
Q4 2017$2,000
-50.0%
15
-77.9%
0.00%
Q3 2017$4,000
-77.8%
68
-88.0%
0.00%
Q1 2016$18,000
-74.3%
567
-52.8%
0.00%
Q4 2015$70,000
+75.0%
1,201
+29.6%
0.00%
Q3 2015$40,0009270.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders